Defining Global Benchmarks for Laparoscopic Right Posterior Sectionectomy/H67: An International Multicenter Study.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
28 Jun 2024
28 Jun 2024
Historique:
medline:
28
6
2024
pubmed:
28
6
2024
entrez:
28
6
2024
Statut:
aheadofprint
Résumé
We aimed to establish global benchmark outcomes indicators for L-RPS/H67. Minimally invasive liver resections has seen an increase in uptake in recent years. Over time, challenging procedures as laparoscopic right posterior sectionectomies (L-RPS)/H67 are also increasingly adopted. This is a post hoc analysis of a multicenter database of 854 patients undergoing minimally invasive RPS (MI-RPS) in 57 international centers in 4 continents between 2015 and 2021. There were 651 pure L-RPS and 160 robotic RPS (R-RPS). Sixteen outcome indicators of low-risk L-RPS cases were selected to establish benchmark cutoffs. The 75th percentile of individual center medians for a given outcome indicator was set as the benchmark cutoff. There were 573 L-RPS/H67 performed in 43 expert centers, of which 254 L-RPS/H67 (44.3%) cases qualified as low risk benchmark cases. The benchmark outcomes established for operation time, open conversion rate, blood loss ≥500 mL, blood transfusion rate, postoperative morbidity, major morbidity, 90-day mortality and textbook outcome after L-RPS were 350.8 minutes, 12.5%, 53.8%, 22.9%, 23.8%, 2.8%, 0% and 4% respectively. The present study established the first global benchmark values for L-RPS/H6/7. The benchmark provided an up-to-date reference of best achievable outcomes for surgical auditing and benchmarking.
Sections du résumé
OBJECTIVE
OBJECTIVE
We aimed to establish global benchmark outcomes indicators for L-RPS/H67.
BACKGROUND
BACKGROUND
Minimally invasive liver resections has seen an increase in uptake in recent years. Over time, challenging procedures as laparoscopic right posterior sectionectomies (L-RPS)/H67 are also increasingly adopted.
METHODS
METHODS
This is a post hoc analysis of a multicenter database of 854 patients undergoing minimally invasive RPS (MI-RPS) in 57 international centers in 4 continents between 2015 and 2021. There were 651 pure L-RPS and 160 robotic RPS (R-RPS). Sixteen outcome indicators of low-risk L-RPS cases were selected to establish benchmark cutoffs. The 75th percentile of individual center medians for a given outcome indicator was set as the benchmark cutoff.
RESULTS
RESULTS
There were 573 L-RPS/H67 performed in 43 expert centers, of which 254 L-RPS/H67 (44.3%) cases qualified as low risk benchmark cases. The benchmark outcomes established for operation time, open conversion rate, blood loss ≥500 mL, blood transfusion rate, postoperative morbidity, major morbidity, 90-day mortality and textbook outcome after L-RPS were 350.8 minutes, 12.5%, 53.8%, 22.9%, 23.8%, 2.8%, 0% and 4% respectively.
CONCLUSIONS
CONCLUSIONS
The present study established the first global benchmark values for L-RPS/H6/7. The benchmark provided an up-to-date reference of best achievable outcomes for surgical auditing and benchmarking.
Identifiants
pubmed: 38939972
doi: 10.1097/SLA.0000000000006418
pii: 00000658-990000000-00961
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Mikel Prieto
(M)
Celine De Meyere
(C)
Juul Meurs
(J)
Kelvin K Ng
(KK)
Kit-Fai Lee
(KF)
Pavel Tarakanov
(P)
Ruslan Alikhanov
(R)
Nita Thiruchelvam
(N)
Jae Young Jang
(JY)
Masayuki Kojima
(M)
Yutaro Kato
(Y)
Jaime Arthur Pirola Kruger
(JAP)
Fabricio Ferreira Coelho
(FF)
Victor Lopez-Lopez
(V)
Margarida Casellas I Robert
(M)
Roberto Montalti
(R)
Mariano Giglio
(M)
Boram Lee
(B)
Hao-Ping Wang
(HP)
Mansour Salleh
(M)
Franco Pascual
(F)
Shian Yu
(S)
Zewei Chen
(Z)
Simone Vani
(S)
Francesco Ardito
(F)
Ugo Giustizieri
(U)
Davide Citterio
(D)
Federico Mocchegiani
(F)
Marco Colasanti
(M)
Giammauro Berardi
(G)
Yoelimar Guzmán
(Y)
Kevin P Labadie
(KP)
Maria Conticchio
(M)
Epameinondas Dogeas
(E)
Emanuele F Kauffmann
(EF)
Mario Giuffrida
(M)
Daniele Sommacale
(D)
Boris Amory
(B)
Paolo Magistri
(P)
Kohei Mishima
(K)
Prashant Kadam
(P)
Chung-Ngai Tang
(CN)
Jacob Ghotbi
(J)
Åsmund Avdem Fretland
(ÅA)
Fabio Forchino
(F)
Alessandro Mazzotta
(A)
Marco Barbara
(M)
Duilio Pagano
(D)
Salvatore Gruttadauria
(S)
Felix Krenzien
(F)
Moritz Schmelzle
(M)
Federica Cipriani
(F)
Chetana Lim
(C)
Junhao Zheng
(J)
Phan Phuoc Nghia
(PP)
Bernardo Dalla Valle
(BD)
Federica Cipriani
(F)
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.